Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,123 across all filing types
Latest filing 2026-01-02 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Stock Exchange. This is a standard regulatory filing required by the HKEX Listing Rules to report monthly movements in securities, share capital, and treasury shares. It does not fit into specific categories like 'Share Issue' (SHA) or 'Transaction in Own Shares' (POS) because it is a comprehensive monthly summary report of all security movements, making 'Regulatory Filings' (RNS) the most appropriate classification for this type of recurring exchange-mandated disclosure.
2026-01-02 English
Terms of Reference of the Nomination Committee of the Board of Directors
Governance Information Classification · 1% confidence The document is titled 'Terms of Reference of the Nomination Committee of the Board of Directors' for PegBio Co., Ltd. It outlines the governance structure, duties, and procedures of a board committee. This type of document is a standard corporate governance policy document, which falls under the 'Governance Information' category as it details internal rules and board structure.
2025-12-23 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Hong Kong Stock Exchange. It details a specific change in the company's issued share capital resulting from a placing of new H shares. This type of filing is a standard regulatory requirement for listed issuers in Hong Kong to report changes in share capital, which falls under the category of share issues or capital changes.
2025-12-22 English
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement regarding the 'Completion of Placing of New H Shares' by PegBio Co., Ltd. It details the issuance of new shares, the use of proceeds from this capital raise, and the resulting changes to the company's share capital structure. This falls under the category of capital raising and financing activities, specifically share issuance.
2025-12-22 English
VOLUNTARY ANNOUNCEMENT NOTICE ABOUT VOLUNTARY EXTENSION OF LOCK-UP PERIOD GIVEN BY A CORNERSTONE INVESTOR
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement from PegBio Co., Ltd. regarding a cornerstone investor's decision to extend the lock-up period for their shares. This relates to capital structure and shareholder commitments rather than financial results, governance, or legal proceedings. Since it does not fit into specific categories like 'Director's Dealing' (which is for individual directors) or 'Major Shareholding Notification' (which is for threshold changes), and it is a specific regulatory announcement regarding share lock-up arrangements, it falls under the general regulatory filing category.
2025-12-15 English
PLACING OF NEW H SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from PegBio Co., Ltd. regarding the 'Placing of New H Shares under General Mandate'. It details the terms of a share placement, including the number of shares, the placing price, the parties involved, and the impact on share capital. This falls squarely under the definition of a 'Share Issue/Capital Change' (SHA) announcement, as it describes the issuance of new equity securities to raise capital.
2025-12-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.